Esther Bowie is an Ophthalmology physician affiliated with Pennsylvania State University. OpenAlex indexes 28 publications with 682 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 University Dr
Hershey, PA 170332360
Telephone
800-243-1455Registry record last updated 18 May 2011.
Clinical trials
- Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease
Sponsor: Medical University of South Carolina
- Diabetic Retinopathy and Sickle Trait
Sponsor: Medical University of South Carolina
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
77%Corticosteroid39.1%Prednisolone Acetate100%Part D≥39 patientsalpha-Adrenergic Agonist14.8%Brimonidine Tartrate71%Brimonidine Tartrate-Timolol29%Part D<11 patients+ 2 more classes in this area
Cardiovascular
13.7%Beta blocker13.7%Timolol Maleate100%Part D<11 patientsMusculoskeletal
9.4%Cyclooxygenase Inhibitor9.4%Ketorolac Tromethamine100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reversible Retinopathy Associated with Fibroblast Growth Factor Receptor Inhibitor
Case Reports in Ophthalmology
2022 - Choroidal Thickness Correlates with Clinical and Imaging Metrics of Parkinson’s Disease: A Pilot Study
Journal of Parkinson s Disease
2021 - Barriers to Attendance among Patients Scheduled for Appointments at an Academic Ophthalmology Practice2021
- Differences in Publication Productivity among Medical and Surgical Retina Specialists at Academic Ophthalmology Departments
Investigative Ophthalmology & Visual Science
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Legro, MD
Pennsylvania State University
Ramin Zand, MD, MPH
Pennsylvania State University
Allan Lipton, MD
Pennsylvania State University
Steven Ettinger, MD
Pennsylvania State University
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”